Overlooked ASX Cannabis Stock with a Global Revenue Footprint
China's Biggest Health Supplements Winners on 6.18 2023 (with historical data) - TMO Group
Elisa Nesta | LinkedIn
Inlight launches new Swisse.com.au - Inlight
PGT Healthcare and Swisse Wellness Join Forces Globally | Business Wire
Faulding taps Chinese vitamin boom after Blackmores, Swisse
Swisse - Inlight
Disney Rethinks India Business Amid Revenue Slump, Losing IPL Rights
Swisse Sale Boosting Blackmores - Forager Funds
H&H Group to showcase China-focused wellness brand portfolio at Virtual travel Retail Expo : The Moodie Davitt Report -The Moodie Davitt Report
Immunity products and China sales a major boost for Swisse-owner H&H as ANZ revenue plunges by a third
Procter and Gamble's Revenue By Segment (2017-2023)
George Livery, Swisse Wellness | PPT
Swisse in rude health as Biostime sale nears | The Australian
Focus: Chinese baby product firms seek to age up, sell more abroad as population falls | Reuters
China's Biggest Health Supplements Winners on 6.18 2023 (with historical data) - TMO Group
H&H Group delivers revenue growth across all three business segments for 2022 and expects positive outlook for 2023
Swisse and Biostime focus: H&H reveals global expansion drive for major brands as revenue grows 2.5%
Cranberry Supplements Market to See Huge Growth by 2027 | Swisse,
Swiss biotech revenue 2015-2022 | Statista
Biostime International Holdings Archives - Just Food
Schweizer: Schweizer Electronic AG: Positive business development in the first quarter of 2023
Health Care Products Market Revenue Growth is Making
H&H Group achieves 13.4% total revenue increase on a reported basis for the nine months to 30 September 2022, boosted by a strong third quarter
